Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Emerging role of mutations in epigenetic regulators including MLL2 derived from The Cancer Genome Atlas for cervical cancer

Fig. 3

Recurrently mutated histone modification regulators harboring mutations destroying phosphorylation sites. EP300, MLL2, ARID1A, CREBBP, and SETD2 are shown in the context of protein domain models derived from UniProt. Each filled circle represents a mutated patient. Somatic missense mutations destroying the phosphorylation sites are marked in red. Domains are depicted with various colors

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us